Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated
with COVID-19 has unique characteristics. Compared with bacterial sepsis, COVID-19 …

Abstract Coronavirus disease 2019 (COVID-19) has emerged as a pandemic at the end of
2019 and continues to exert an unfavorable worldwide health impact on a large proportion …

Numerous studies have linked coronavirus disease 2019 (COVID‐19) with endothelial
dysfunction and reported elevated levels of endothelial biomarkers in this disease. We …

COVID-19 is characterized by vascular inflammation and thrombosis, including elevations in
P-selectin, a mediator of inflammation released by endothelial cells. We tested the effect of P …

In severe COVID-19, which is characterized by blood clots and neutrophil-platelet
aggregates in the circulating blood and different tissues, an increased incidence of …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led
to an unprecedented global healthcare crisis. While SARS-CoV-2-associated COVID-19 …

Abstract During SARS-CoV-2 infection, an effective immune response provides the first line
of defense; however, excessive inflammatory innate immunity and impaired adaptive …

Background Inflammation is at the core of many chronic conditions and exacerbates
infectious conditions, including the severity of coronavirus disease 2019 (COVID-19) …

Abstract Background Annexin A1 (AnxA1) is an important endogenous glucocoticoid protein
that contributes to the suppression of inflammation by limiting the production of neutrophil …

Thrombosis is the major cause of death in severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) infection, and the pathology of vascular endothelial cells (ECs) has received …